Focus Partners Advisor Solutions’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
7,504
+382
+5% +$57.3K 0.01% 521
2026
Q1
$1.09M Buy
7,122
+707
+11% +$108K 0.01% 534
2025
Q4
$885K Sell
6,415
-479
-7% -$62.7K 0.01% 537
2025
Q3
$882K Buy
6,894
+139
+2% +$17K 0.01% 573
2025
Q2
$817K Buy
6,755
+73
+1% +$8.23K 0.01% 504
2025
Q1
$745K Buy
6,682
+2,282
+52% +$243K 0.01% 455
2024
Q4
$428K Buy
4,400
+1,468
+50% +$157K 0.01% 511
2024
Q3
$337K Buy
2,932
+719
+32% +$81.6K 0.01% 534
2024
Q2
$236K Sell
2,213
-1,289
-37% -$129K 0.01% 557
2024
Q1
$339K Buy
+3,502
New +$359K 0.01% 437
2023
Q4
Sell
-2,779
Closed -$283K 453
2023
Q3
$283K Buy
2,779
+361
+15% +$36.6K 0.01% 357
2023
Q2
$244K Buy
2,418
+72
+3% +$7.2K 0.01% 330
2023
Q1
$216K Sell
2,346
-1,031
-31% -$90K 0.01% 321
2022
Q4
$306K Sell
3,377
-181
-5% -$15.2K 0.02% 260
2022
Q3
$270K Buy
3,558
+1,031
+41% +$85.5K 0.02% 325
2022
Q2
$214K Buy
2,527
+53
+2% +$4.65K 0.02% 323
2022
Q1
$217K Sell
2,474
-863
-26% -$74.7K 0.02% 295
2021
Q4
$291K Buy
+3,337
New +$277K 0.06% 97

Other funds holding NVS

Focus Partners Advisor Solutions's NVS Position: Q2 2026 in Review

Focus Partners Advisor Solutions increased its Novartis (NVS) stake by 5.4% in Q2 2026, buying an estimated $57.3K and bringing the position to 7,504 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #521.

Focus Partners Advisor Solutions first reported a position in NVS in Q4 2021 and has held it in 18 quarters since. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Focus Partners Advisor Solutions held 7,504 shares of Novartis worth $1.18M as of Q2 2026.
  • Focus Partners Advisor Solutions bought 382 Novartis shares in Q2 2026, an estimated $57.3K.
  • Novartis made up 0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #521 holding.
  • Focus Partners Advisor Solutions first reported a position in Novartis in Q4 2021 and has held it in 18 quarters since.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.